Cargando…

Risk factors for totally implantable access ports-associated thrombosis in pediatric oncology patients

The application of totally implantable access ports (TIAPs) reduces treatment-related discomfort; however, the existence of catheter may cause side effects, with the most common one being the occurrence of TIAPs-associated thrombosis. The risk factors for TIAPs-associated thrombosis in pediatric onc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lan, Yingxia, Wu, Liuhong, Guo, Jin, Wang, Juan, Guan, Huijie, Li, Baihui, Liu, Longzhen, Zhang, Lian, Hong, Ye, Deng, Jun, Zhu, Jia, Lu, Suying, Sun, Feifei, Huang, Junting, Sun, Xiaofei, Zhang, Yizhuo, Wang, Jian, Cai, Ruiqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981621/ https://www.ncbi.nlm.nih.gov/pubmed/36864082 http://dx.doi.org/10.1038/s41598-023-30763-0

Ejemplares similares

Oral vinorelbine and continuous low doses of cyclophosphamide in pediatric rhabdomyosarcoma: a real-world study
por: Lan, Yingxia, et al.
Publicado: (2023)

The Efficacy and Safety of Apatinib in Refractory/Relapse Advanced Pediatric Solid Tumor: A Retrospective Study
por: Sun, Feifei, et al.
Publicado: (2020)

Irinotecan Plus Doxorubicin Hydrochloride Liposomes for Relapsed or Refractory Wilms Tumor
por: Wang, Juan, et al.
Publicado: (2021)

Bioinformatics Analysis and Validation Identify CDK1 and MAD2L1 as Prognostic Markers of Rhabdomyosarcoma
por: Lu, Suying, et al.
Publicado: (2020)

The Efficacy and Safety of Anlotinib in Pediatric Patients With Refractory or Recurrent Solid Tumors
por: Lu, Suying, et al.
Publicado: (2022)

Combination Therapy With Anti-PD-1 or PD-1 Antibody Alone in Asian Pediatric Patients With Relapsed or Refractory Cancer
por: Que, Yi, et al.
Publicado: (2021)

Outcomes of Burkitt lymphoma with bone marrow involvement or Burkitt leukemia in Chinese children
por: Zhu, Jia, et al.
Publicado: (2021)

Influence of UGT1A1 *6/*28 Polymorphisms on Irinotecan-Related Toxicity and Survival in Pediatric Patients with Relapsed/Refractory Solid Tumors Treated with the VIT Regimen
por: Zhu, Xiaoqin, et al.
Publicado: (2021)

Vincristine, Irinotecan, and Temozolomide in Patients With Relapsed/Refractory Neuroblastoma
por: Zhu, Jia, et al.
Publicado: (2022)

Multimodal Treatment of Children With Sacrococcygeal Yolk Sac Tumor: Retrospective Analysis of Clinicopathology Characteristics and Relapse-free Survival
por: Zhu, Jia, et al.
Publicado: (2021)

Long‐term follow‐up results of pediatric and adolescent patients with localized Ewing sarcoma treated based on stratified modalities
por: Zeng, Chenggong, et al.
Publicado: (2023)

Identification of prognostic immune-related genes in rhabdoid tumor of kidney based on TARGET database analysis
por: Chen, Huimou, et al.
Publicado: (2021)

IDO1 plays a tumor-promoting role via MDM2-mediated suppression of the p53 pathway in diffuse large B-cell lymphoma
por: Sun, Chengtao, et al.
Publicado: (2022)

Investigation of chemoresistance to first-line chemotherapy and its possible association with autophagy in high-risk neuroblastoma
por: Chen, Tingting, et al.
Publicado: (2022)

Efficacy and safety of programmed cell death receptor 1 inhibition-based regimens in patients with pediatric malignancies: the real-world study in China
por: Hong, Ye, et al.
Publicado: (2023)

Oral Metronomic Maintenance Therapy Can Improve Survival in High-Risk Neuroblastoma Patients Not Treated with ASCT or Anti-GD2 Antibodies
por: Sun, Xiaofei, et al.
Publicado: (2021)

CHIC Risk Stratification System for Predicting the Survival of Children With Hepatoblastoma: Data From Children With Hepatoblastoma in China
por: Huang, Junting, et al.
Publicado: (2020)

Influence of Methylenetetrahydrofolate Reductase C677T and A1298C Polymorphism on High-Dose Methotrexate-Related Toxicities in Pediatric Non-Hodgkin Lymphoma Patients
por: Lu, Suying, et al.
Publicado: (2021)

ISL1 promoted tumorigenesis and EMT via Aurora kinase A-induced activation of PI3K/AKT signaling pathway in neuroblastoma
por: Li, Mengzhen, et al.
Publicado: (2021)

Safety and clinical efficacy of sintilimab (anti-PD-1) in pediatric patients with advanced or recurrent malignancies in a phase I study
por: Que, Yi, et al.
Publicado: (2023)

MDM2-P53 Signaling Pathway-Mediated Upregulation of CDC20 Promotes Progression of Human Diffuse Large B-Cell Lymphoma
por: Sun, Chengtao, et al.
Publicado: (2020)

Cost-utility analysis of centrally inserted totally implanted access port (PORT) vs. peripherally inserted central catheter (PICC) in the oncology chemotherapy
por: Shao, Guoliang, et al.
Publicado: (2022)

Single-port access versus conventional multi-port access total laparoscopic hysterectomy for very large uterus
por: Lee, Jinhwa, et al.
Publicado: (2015)

An inflammation-based cumulative prognostic score system in patients with diffuse large B cell lymphoma in rituximab era
por: Sun, Feifei, et al.
Publicado: (2018)

Role of post-chemotherapy radiation in the management of children and adolescents with primary advanced malignant mediastinal germ cell tumors
por: Huang, Junting, et al.
Publicado: (2017)

Unsuccessful removal of a totally implantable venous access port caused by thrombosis in the left brachiocephalic vein: A case report
por: Zhang, Xi, et al.
Publicado: (2019)

KDM5B promotes tumorigenesis of Ewing sarcoma via FBXW7/CCNE1 axis
por: Chen, Binbin, et al.
Publicado: (2022)

Shanghai expert consensus on totally implantable access ports 2019
por: Ding, Xiaoyi, et al.
Publicado: (2019)

Two-port access versus four-port access laparoscopic ovarian cystectomy
por: Choi, Won-Kyu, et al.
Publicado: (2014)

Long-Term Outcomes of Nasopharyngeal Carcinoma in 148 Children and Adolescents
por: Lu, Suying, et al.
Publicado: (2016)

Utility of totally implantable venous access ports in patients with breast cancer
por: Zhang, Peng, et al.
Publicado: (2019)

Single port varicocelectomy using SILS™ multiple access port
por: Choi, Hoon, et al.
Publicado: (2015)

A multicenter phase II trial of primary prophylactic PEG‐rhG‐CSF in pediatric patients with solid tumors and non‐Hodgkin lymphoma after chemotherapy: An interim analysis
por: Huang, Junting, et al.
Publicado: (2023)

The Pathogenesis and Prevention of Port-Site Metastasis in Gynecologic Oncology
por: Gao, Qianqian, et al.
Publicado: (2020)

Comparison of peripherally inserted central catheters (PICCs) versus totally implantable venous-access ports in pediatric oncology patients, a single center study
por: Zhang, Hong, et al.
Publicado: (2022)

Risk factors for unsuccessful removal of central venous access ports implanted in the forearm of adult oncologic patients
por: Kinoshita, Mitsuhiro, et al.
Publicado: (2021)

Management of outpatient with totally implantable venous access Ports during the COVID-19 epidemic
por: Yan, Weipeng, et al.
Publicado: (2021)

Single Port Access (SPA) Splenectomy
por: Rottman, Steven J., et al.
Publicado: (2010)

Treatment of portal vein thrombosis using vascular access port implantation in a Dalmatian dog: A case report
por: Yoshida, Tomohiko, et al.
Publicado: (2022)

Laparoscopic vaginal vault closure with conventional straight instruments in single-port access total laparoscopic hysterectomy
por: Park, Daehyun, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_fq5n6i6mb0tturvpfnkcd8r59h